HUTCHMED (China) Limited

As of December 31, 2025, HUTCHMED (China) Limited carries a market capitalization of 178.83B, placing it among publicly traded companies globally. Its enterprise value stands at 85.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HUTCHMED (China) Limited's next confirmed earnings release is scheduled for March 4, 2027.

As of December 31, 2025, HUTCHMED (China) Limited has 859.74M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, HUTCHMED (China) Limited maintains a current ratio of 4.96, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, HUTCHMED (China) Limited's stock has declined approximately 7.84% over the past 52 weeks. The 50-day moving average sits at 203.96, while the 200-day moving average is 197.27.

As of December 31, 2025, HUTCHMED (China) Limited holds 101.47B in cash and equivalents against 7.27B in total debt, resulting in a net debt position of 1.62B. Total book value stands at 91.87B, with working capital of 92.89B providing operational flexibility.